Fluconazole

TargetMol
Product Code: TAR-T1388
Supplier: TargetMol
CodeSizePrice
TAR-T1388-1mL1 mL * 10 mM (in DMSO)£95.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1388-50mg50mg£102.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1388-100mg100mg£109.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1388-200mg200mg£118.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1388-500mg500mg£128.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Triazole antifungal agent that is used to treat oropharyngeal candidiasis and cryptococcal meningitis in AIDS.
CAS:
86386-73-4
Formula:
C13H12F2N6O
Molecular Weight:
306.277
Pathway:
Microbiology/Virology
Purity:
0.9917
SMILES:
OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F
Target:
Antibiotic; Antifection; Antifungal

References

1. Uppuluri P, et al. Antimicrob Agents Chemother, 2008, 52(3), 1127-1132. 2. Rogers TE, et al. Antimicrob Agents Chemother, 1986, 30(3), 418-422. 3. Chin NX, et al. Antimicrob Agents Chemother, 1997, 41(4), 850-852. 4. Larsen RA, et al. Antimicrob Agents Chemother, 1996, 40(9), 2178-2182. 5. Kuang Y, Chai Y, Xu L, et al. Glabrone as a specific UGT1A9 probe substrate and its application in discovering the inhibitor glycycoumarin[J]. European Journal of Pharmaceutical Sciences. 2021: 105786. 6. Tsang C C, Chan K F, Chan W, et al. Hepatic phaeohyphomycosis due to a novel dematiaceous fungus, Pleurostoma hongkongense sp. nov., and importance of antifungal susceptibility testing[J]. Emerging Microbes & Infections. 2020: 1-53. 7. Tsang C C, Tang J Y M, Chan K F, et al. Diversity of phenotypically non-dermatophyte, non-Aspergillus filamentous fungi causing nail infections: importance of accurate identification and antifungal susceptibility testing[J]. Emerging microbes & infections. 2019;8(1):531-541.